Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial

BACKGROUND: Lung cancer is the most common cause of cancer related death worldwide. The majority of cases are detected at a late stage when prognosis is poor. The EarlyCDT®-Lung Test detects autoantibodies to abnormal cell surface proteins in the earliest stages of the disease which may allow tumour...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, F. M., Farmer, Eoghan, Mair, Frances S., Treweek, Shaun, Kendrick, Denise, Jackson, Cathy, Robertson, Chris, Briggs, Andrew, McCowan, Colin, Bedford, Laura, Young, Ben, Vedhara, Kavita, Gallant, Stephanie, Littleford, Roberta, Robertson, John, Sewell, Herb, Dorward, Alistair, Sarvesvaran, Joseph, Schembri, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346215/
https://www.ncbi.nlm.nih.gov/pubmed/28284200
http://dx.doi.org/10.1186/s12885-017-3175-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346215/
https://www.ncbi.nlm.nih.gov/pubmed/28284200
http://dx.doi.org/10.1186/s12885-017-3175-y

Ejemplares similares